Modelling the potential impacts of limiting vaping product sales to pharmacies

"Restricting e-cigarettes to over-the-counter pharmacy access in NZ reduced 18-24 yr old vaping prevalence by 6% and increased health-adjusted life years (HALYs) while averting premature deaths". That's good, right? https://t.co/2WZHl11FXL

Evidence from NZ that higher youth vaping means higher youth smoking. "Under the ‘high’ BAU scenario (60% vaping) interventions marginally increased smoking (2% for OTC)". While #PharmacyModel "modest reductions in vaping prevalence and net health gains".…